Clinical experience with tolvaptan in patients with polycystic kidney disease

Med Clin (Barc). 2020 Jul 24;155(2):83-84. doi: 10.1016/j.medcli.2019.03.011. Epub 2019 May 23.

[Article in English, Spanish]

Authors

Covadonga López Del Moral Cuesta¹, Gema Fernández Fresnedo², Luis Martín Penagos²

Affiliations

¹ Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España. Electronic address: covalopezdelmoral@gmail.com.
² Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España.

PMID: 31130311
DOI: 10.1016/j.medcli.2019.03.011

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antidiuretic Hormone Receptor Antagonists / therapeutic use
Benzazepines / therapeutic use
Humans
Polycystic Kidney Diseases*
Polycystic Kidney, Autosomal Dominant* / complications
Polycystic Kidney, Autosomal Dominant* / drug therapy
Tolvaptan

Substances

Antidiuretic Hormone Receptor Antagonists
Benzazepines
Tolvaptan